INDAPTUS THERAPEUTICS INC (INDP) Stock Balance Sheet
NASDAQ:INDP - Nasdaq - US45339J1051 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 5.79M | 13.36M | 9.63M | 39.13M | 14.67M | |||
| Marketable Securities | N/A | 0.00 | 16.81M | N/A | N/A | |||
| Receivables | N/A | N/A | N/A | 1.11M | 90.00K | |||
| Other Current Assets | 831.60K | 633.20K | 810.00K | 1.26M | 210.00K | |||
| Total Current Assets | 6.62M | 14.00M | 27.24M | 40.39M | 14.97M | |||
| Non-Current Assets | ||||||||
| PPE Net | 82.20K | 173.90K | 80.00K | 170.00K | 2.21M | |||
| Other Non-Current Assets | 638.30K | 754.70K | 740.00K | 20.00K | 3.72M | |||
| Total Non-Current Assets | 720.50K | 928.70K | 820.00K | 190.00K | 5.93M | |||
| TOTAL ASSETS | 7.34M | 14.92M | 28.06M | 40.58M | 20.90M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 2.52M | 1.97M | 2.06M | 100.00K | 600.00K | |||
| Accounts Payable | 870.20K | 806.00K | 1.38M | 4.51M | 370.00K | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | 4.37M | |||
| Total Current Liabilities | 3.39M | 2.77M | 3.43M | 4.60M | 5.33M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 0.00 | 73.40K | 0.00 | 70.00K | 1.03M | |||
| Total Non-Current Liabilities | 0.00 | 73.40K | 0.00 | 80.00K | 1.03M | |||
| TOTAL LIABILITIES | 3.39M | 2.85M | 3.43M | 4.68M | 6.36M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -60.44M | -45.42M | -29.99M | -15.67M | -203.55M | |||
| Additional Paid In Capital | 64.26M | 57.41M | 54.44M | 51.49M | 217.36M | |||
| Common Shares | 120.10K | 84.00K | 80.00K | 80.00K | 730.00K | |||
| Other Shareholders' Equity | N/A | 0.00 | 100.00K | N/A | N/A | |||
| Shares Outstanding | 12.01M | 8.40M | 8.40M | 8.26M | 1.08M | |||
| Tangible Book Value per Share | 0.33 | 1.44 | 2.93 | 4.35 | 13.45 | |||
| Total Shareholders' Equity | 3.94M | 12.08M | 24.63M | 35.90M | 14.53M | |||
| TOTAL LIABILITIES AND EQUITY | 7.34M | 14.92M | 28.06M | 40.58M | 20.90M | |||
| Statistics | ||||||||
| Current Ratio | 1.95 | 5.05 | 7.94 | 8.78 | 2.81 | |||
| Return On Assets (ROA) | -204.69% | -103.35% | -51.03% | -19.00% | -67.61% | |||
| Return On Equity (ROE) | -380.80% | -127.71% | -58.14% | -21.48% | -97.25% | |||
All data in USD , ROIC based on taxRate of 0.21